Parasitology and Mycology Rapid Tests and POC - Medical Devices Pipeline Product Landscape, 2021
October 2021
133
About the Report
About the Report
Parasitology and Mycology Rapid Tests and POC-Medical Devices Pipeline Product Landscape, 2021
Summary
GlobalData's Medical Devices sector report, Parasitology and Mycology Rapid Tests and POC-Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Parasitology & Mycology Rapid Tests & POC pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Parasitology & Mycology Rapid Tests & POC sub-segment comprises of rapid test kits intended for rapid diagnosis, with immediate results, through immuno assays for Plasmodium and Candida albicans.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Parasitology & Mycology Rapid Tests & POC under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Parasitology & Mycology Rapid Tests & POC and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to-
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Parasitology & Mycology Rapid Tests & POC under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Products
Companies
Abingdon Health PLC Access Bio Inc AdvanDx Inc (Inactive) Ampath Trust Amplino B.V. BBB Technologies Inc Binx Health Inc Biomagnetics Diagnostics Corp Biopromic AB Biotech Resources Aust Pty Ltd Boston University Bruker Daltonik GmbH Cepheid Inc Ceres Nanosciences Inc Chembio Diagnostic Systems Inc Colorado State University CrossLife Technologies Inc DetectoGen Inc D-Kimia, LLC. DxDiscovery Inc Eiken Chemical Co Ltd Foundation for Innovative New Diagnostics genedrive plc GenePOC Inc GlucoSentient Inc Group K Diagnostics Illucidx Inc Immuno-Mycologics Inc Innova Biotechnology Co Ltd Institute for Development Research Institute of Molecular Biology of Parana IPI Singapore Johns Hopkins University Kephera Diagnostics LLC Labsystems Diagnostics Oy Lynntech Inc Makerere University Meridian Bioscience Inc Michigan State University Micronics Inc MiraVista Diagnostics LLC Molbio Diagnostics Pvt Ltd Mologic Ltd MycoDART Inc MyMD Pharmaceuticals, Inc NanoRepro AG NG Biotech NOWDiagnostics Inc OLM Diagnostics Ltd Omega Diagnostics Group Plc Oregon Health & Science University PATH medical GmbH Protein Advances Inc Quidel Corp RNA Disease Diagnostics Inc Rutgers The State University of New Jersey Salignostics Ltd Salva Biotech Inc Scanogen Inc SD Biosensor Inc Seattle Children's Hospital Selfdiagnostics OU Singapore Immunology Network Tangen Biosciences Inc Technical University of Munich Trinity Biotech Plc University of Antwerp University of California, Merced University of Delhi University of Kansas Medical Center University of Nevada Reno University of Zurich Ustar Biotechnologies (Hangzhou) Ltd. Vanderbilt University Whidiag SAS Yaathum Biotech Pvt Ltd
Table of Contents
Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Parasitology & Mycology Rapid Tests & POC Overview
3 Products under Development
3.1 Parasitology & Mycology Rapid Tests & POC-Pipeline Products by Stage of Development
3.2 Parasitology & Mycology Rapid Tests & POC-Pipeline Products by Territory
3.3 Parasitology & Mycology Rapid Tests & POC-Pipeline Products by Regulatory Path
3.4 Parasitology & Mycology Rapid Tests & POC-Pipeline Products by Estimated Approval Date
4 Parasitology & Mycology Rapid Tests & POC-Pipeline Products under Development by Companies
4.1 Parasitology & Mycology Rapid Tests & POC Companies-Pipeline Products by Stage of Development
4.2 Parasitology & Mycology Rapid Tests & POC-Pipeline Products by Stage of Development
5 Parasitology & Mycology Rapid Tests & POC Companies and Product Overview
6 Parasitology & Mycology Rapid Tests & POC- Recent Developments
6.1 Sep 07, 2021: binx health adds Industry Leaders, Elizabeth Mora, and Naomi Kelman to Board of Directors
6.2 Jul 16, 2021: Trinity Biotech Provides a Business Development Update For Q2 2021
6.3 May 25, 2021: Trinity Biotech Announces Results for Q1 2021
6.4 Mar 25, 2021: Trinity Biotech Announces Quarter 4 and Fiscal Year 2020 Financial Results
6.5 Nov 17, 2020: Trinity Biotech plc to Announce Third Quarter 2020 Financial Results
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
List of Figure
List of Figures
Parasitology & Mycology Rapid Tests & POC-Pipeline Products by Stage of Development
Parasitology & Mycology Rapid Tests & POC-Pipeline Products by Territory
Parasitology & Mycology Rapid Tests & POC-Pipeline Products by Regulatory Path
List of Table
List of Tables
Parasitology & Mycology Rapid Tests & POC-Pipeline Products by Stage of Development
Parasitology & Mycology Rapid Tests & POC-Pipeline Products by Territory
Parasitology & Mycology Rapid Tests & POC-Pipeline Products by Regulatory Path
Parasitology & Mycology Rapid Tests & POC-Pipeline Products by Estimated Approval Date
Parasitology & Mycology Rapid Tests & POC Companies-Pipeline Products by Stage of Development
Parasitology & Mycology Rapid Tests & POC-Pipeline Products by Stage of Development
Glossary
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.